KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 10, 2014, Pages 2092-2102

  Yang, Shu ^a   Li, Wen shuai ^a   Dong, Fang ^a   Sun, Hai mei ^a   Wu, Bo ^a   Tan, Jun ^a   Zou, Wan jing ^a   Zhou, De shan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer cell; KITLG; miR 34c; Tumour suppressor

Indexed keywords

MESSENGER RNA; MICRORNA; MIRN34 MICRORNA, HUMAN; SMALL INTERFERING RNA; STEM CELL FACTOR;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STEM CELL FACTOR; TUMOR CELLS, CULTURED;

EID: 84908024091     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12368     Document Type: Article

References (39)

1. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449: 682-8.
2. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008; 27: 2128-36.
3. Gao C, Zhang Z, Liu W, et al. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer. 2010; 116: 41-9.
4. Galardi S, Mercatelli N, Farace MG, et al. NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res. 2011; 39: 3892-902.
5. Li S, Li Z, Guo F, et al. miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma. J Biomed Sci. 2011; 18: 24.
6. Corney DC, Flesken-Nikitin A, Godwin AK, et al. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 2007; 67: 8433-8.
7. Toyota M, Suzuki H, Sasaki Y, et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008; 68: 4123-32.
8. Hagman Z, Larne O, Edsjö A, et al. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int J Cancer. 2010; 127: 2768-76.
9. Yu F, Jiao Y, Zhu Y, et al. MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem. 2012; 287: 465-73.
10. Catuogno S, Cerchia L, Romano G, et al. miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. Oncogene. 2013; 32: 341-51.
11. Kim NH, Cha YH, Kang SE, et al. p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells. Cell Cycle. 2013; 12: 1578-87.
12. Kim NH, Kim HS, Kim NG, et al. p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal. 2011a; 4: ra71.
13. Kim NH, Kim HS, Li XY, et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol. 2011b; 195: 417-33.
14. Roy S, Levi E, Majumdar AP, et al. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J Hematol Oncol. 2012; 5: 58. Doi:10.1186/1756-8722-5-58.
15. Horváth VJ, Vittal H, Lörincz A, et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology. 2006; 130: 759-70.
16. Miyoshi T, Otsuka F, Nakamura E, et al. Regulatory role of kit ligand-c-kit interaction and oocyte factors in steroidogenesis by rat granulosa cells. Mol Cell Endocrinol. 2012; 358: 18-26.
17. Rovasio RA, Faas L, Battiato NL. Insights into stem cell factor chemotactic guidance of neural crest cells revealed by a real-time directionality-based assay. Eur J Cell Biol. 2012; 91: 375-90.
18. Lefevre G, Glotin AL, Calipel A, et al. Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis. J Biol Chem. 2004; 279: 31769-79.
19. Mashour GA, Driever PH, Hartmann M, et al. Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1. Clin Cancer Res. 2004; 10: 5677-83.
20. Sun L, Hui AM, Su Q, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 2006; 9: 287-300.
21. Han ZB, Ren H, Zhao H, et al. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis. 2008; 29: 1853-61.
22. Levina V, Marrangoni A, Wang T, et al. Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kitautocrine signaling loop. Cancer Res. 2010; 70: 338-46.
23. Théou-Anton N, Tabone S, Brouty-Boyé D, et al. Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism. Br J Cancer. 2006; 94: 1180-5.
24. Martinho O, Gonçalves A, Moreira MA, et al. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops. Gynecol Oncol. 2008; 111: 350-5.
25. Bellone G, Carbone A, Sibona N, et al. Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. Cancer Res. 2001; 61: 2200-6.
26. Bellone G, Silvestri S, Artusio E, et al. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1. J Cell Physiol. 1997; 172: 1-11.
27. Bellone G, Smirne C, Carbone A, et al. KIT/stem cell factor expression in premalignant lesions of the colon mucosa in relationship to disease progression and outcomes. Int J Oncol. 2006; 29: 851-9.
28. Hellevik T, Pettersen I, Berg V, et al. Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced. Radiat Oncol. 2012; 7: 59.
29. Yasuda A, Sawai H, Takahashi H, et al. Stem cell factor/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K/Akt pathway. Dig Dis Sci. 2007; 52: 2292-300.
30. Vogt M, Munding J, Grüner M, et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch. 2011; 458: 313-22.
31. Kaller M, Liffers ST, Oeljeklaus S, et al. Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol Cell Proteomics. 2011; 10: M111.010462. Doi:10.1074/mcp.M111.010462.
32. Siemens H, Jackstadt R, Kaller M, et al. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget. 2013; 4: 1399-415.
33. Krasagakis K, Kruger-Krasagakis S, Eberle J, et al. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma. Dermatology. 2009; 218: 37-43.
34. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer. 2012; 12: 613-26.
35. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010; 17: 193-9.
36. Cai KM, Bao XL, Kong XH, et al. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int J Mol Med. 2010; 25: 565-71.
37. Reed J, Ouban A, Schickor FK, et al. Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma. Clin Colorectal Cancer. 2002; 2: 119-22.
38. Yorke R, Chirala M, Younes M. c-kit proto-oncogene product is rarely detected in colorectal adenocarcinoma. J Clin Oncol. 2003; 21: 3885-6.
39. Dong F, Lou D. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. Mol Vis. 2012; 18: 537-46.